J. P. Annes, J. S. Munger, and D. B. And-rifkin, Making sense of latent TGFbeta activation, Journal of Cell Science, vol.116, issue.2, pp.217-224, 2003.
DOI : 10.1242/jcs.00229

S. Ansieau, G. Collin, and L. Hill, EMT or EMT-Promoting Transcription Factors, Where to Focus the Light?, Frontiers in Oncology, vol.28, p.353, 2014.
DOI : 10.1128/MCB.02061-07

C. J. Aslakson and F. R. Miller, Selective Events in the Metastatic Process Defined by Analysis of the Sequential Dissemination of Subpopulations of a Mouse Mammary Tumor, Cancer research, vol.52, pp.1399-1405, 1992.

M. Campone, I. Valo, P. Jezequel, M. Moreau, A. Boissard et al., Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples, Molecular & Cellular Proteomics, vol.240, issue.4, pp.2936-2946, 2015.
DOI : 10.1158/1055-9965.EPI-09-0456

V. G. Cooke, V. S. Lebleu, D. Keskin, Z. Khan, J. T. Connell et al., Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway, Cancer Cell, vol.21, issue.1, pp.66-81, 2012.
DOI : 10.1016/j.ccr.2011.11.024

S. E. Crawford, V. Stellmach, U. J. Murphy, S. M. Ribeiro, J. Lawler et al., Thrombospondin-1 Is a Major Activator of TGF-??1 In Vivo, Cell, vol.93, issue.7, pp.1159-1170, 1998.
DOI : 10.1016/S0092-8674(00)81460-9

V. Firlej, J. R. Mathieu, C. Gilbert, L. Lemonnier, J. Nakhlé et al., Thrombospondin-1 Triggers Cell Migration and Development of Advanced Prostate Tumors, Cancer Research, vol.71, issue.24, pp.7649-7658, 2011.
DOI : 10.1158/0008-5472.CAN-11-0833

K. R. Fischer, A. Durrans, S. Lee, J. Sheng, F. Li et al., Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance, Nature, vol.5, issue.7579, pp.472-476, 2015.
DOI : 10.1038/cddis.2014.115
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662610/pdf

A. Fontana, S. Filleur, J. Guglielmi, L. Frappart, G. Bruno-bossio et al., Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1in vivo, International Journal of Cancer, vol.63, issue.5, 2005.
DOI : 10.1016/S0002-9440(10)65041-9

D. M. Gilkes, G. L. Semenza, and D. Wirtz, Hypoxia and the extracellular matrix: drivers of tumour metastasis, Nature Reviews Cancer, vol.18, issue.6, pp.686-691, 2014.
DOI : 10.1096/fj.03-0699com

B. Gyorffy, A. Lanczky, A. C. Eklund, C. Denkert, J. Budczies et al., An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients, Breast Cancer Research and Treatment, vol.7, issue.4, pp.725-731, 2010.
DOI : 10.1016/S0140-6736(05)17947-1
URL : https://hal.archives-ouvertes.fr/hal-00520003

S. M. Hatfield, J. Kjaergaard, D. Lukashev, T. H. Schreiber, B. Belikoff et al., Immunological mechanisms of the antitumor effects of supplemental oxygenation, Science Translational Medicine, vol.60, issue.277, pp.277-230, 2015.
DOI : 10.1016/j.jcrc.2006.12.002

S. Herbertz, J. S. Sawyer, A. J. Stauber, I. Gueorguieva, K. E. Driscoll et al., Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway, p.44794499, 2015.

H. Horiguchi, S. Yamagata, Z. Rong-qian, S. Kagawa, and N. Sakashita, Thrombospondin-1 is highly expressed in desmoplastic components of invasive ductal carcinoma of the breast and associated with lymph node metastasis, The Journal of Medical Investigation, vol.60, issue.1.2, p.9196, 2013.
DOI : 10.2152/jmi.60.91

R. K. Jain, Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia, Cancer Cell, vol.26, issue.5, pp.605-622, 2014.
DOI : 10.1016/j.ccell.2014.10.006

A. Jayachandran, M. Anaka, P. Prithviraj, C. Hudson, S. J. Mckeown et al., Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma, Oncotarget, vol.5, issue.14, pp.5782-5797, 2014.
DOI : 10.18632/oncotarget.2164

B. Jimenez, O. V. Volpert, S. E. Crawford, M. Febbraio, R. L. Silverstein et al., Signals leading to apoptosis-dependent inhibition of neovascularizationby thrombospondin-1, Nature Medicine, vol.274, issue.1, pp.41-48, 2000.
DOI : 10.1074/jbc.274.27.19055

H. Maes, A. Kuchnio, A. Peric, S. Moens, K. Nys et al., Tumor Vessel Normalization by Chloroquine Independent of Autophagy, Cancer Cell, vol.26, issue.2, pp.190-206, 2014.
DOI : 10.1016/j.ccr.2014.06.025

G. Mountzios, G. Pentheroudakis, C. , and P. , Bevacizumab and micrometastases, 2014.

J. E. Murphy-ullrich and E. H. Sage, Revisiting the matricellular concept, Matrix Biology, vol.37, 2014.
DOI : 10.1016/j.matbio.2014.07.005

F. E. Nathan, E. Hernandez, C. J. Dunton, J. Treat, H. I. Switalska et al., Plasma thrombospondin levels in patients with gynecologic malignancies, Cancer, vol.53, issue.11, pp.2853-2858, 1994.
DOI : 10.7326/0003-4819-95-5-636

E. Priolo, C. Puxeddu, and E. , B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression, Proc Natl Acad Sci, vol.107, pp.10649-10654, 2010.

K. Okada, K. Hirabayashi, T. Imaizumi, M. Matsuyama, N. Yazawa et al., Stromal thrombospondin-1 expression is a prognostic indicator and a new marker of invasiveness in intraductal papillary-mucinous neoplasm of the pancreas, Biomedical Research, vol.31, issue.1, 2010.
DOI : 10.2220/biomedres.31.13

E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Viñals et al., Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis, Biomed Res, vol.31, pp.13-19, 2009.

C. Park, J. Son, C. H. Jin, J. Nam, D. Kim et al., EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung, European Journal of Cancer, vol.47, issue.17, pp.2642-2653, 2011.
DOI : 10.1016/j.ejca.2011.07.007

D. Pectasides, G. Papaxoinis, V. Kotoula, H. Fountzilas, I. Korantzis et al., Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) study The roles of TGF[beta] in the tumour microenvironment, Oncol Rep Nat Rev Cancer, vol.27, issue.13, pp.216-224, 2012.

S. M. Ribeiro, M. Poczatek, S. Schultz-cherry, M. Villain, and J. E. Murphy-ullrich, The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-??, Journal of Biological Chemistry, vol.264, issue.19, pp.13586-13593, 1999.
DOI : 10.1016/S0092-8674(00)80545-0

M. Rusnati, C. Urbinati, S. Bonifacio, M. Presta, and G. Taraboletti, Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action, Pharmaceuticals, vol.82, issue.12, pp.1241-1278, 2010.
DOI : 10.1016/j.bbamcr.2006.08.001

I. Sargiannidou, C. Qiu, and G. P. Tuszynski, Mechanisms of thrombospondin-1mediated metastasis and angiogenesis, Semin Thromb Hemost, vol.30, pp.127-136, 2004.

E. A. Scheef, C. M. Sorenson, and N. Sheibani, Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1, American Journal of Physiology-Cell Physiology, vol.296, issue.4, pp.724-734, 2009.
DOI : 10.1002/dvdy.20837

M. M. Shull, I. Ormsby, A. B. Kier, S. Pawlowskr, R. J. Diebold et al., Targeted disruption of the mouse transforming growth factor-??1 gene results in multifocal inflammatory disease, Nature, vol.359, issue.6397, pp.693-699, 1992.
DOI : 10.1038/359693a0

O. Stenina-adognravi, Invoking the power of thrombospondins: Regulation of thrombospondins expression, Matrix Biology, vol.37, pp.69-82, 2014.
DOI : 10.1016/j.matbio.2014.02.001

E. J. Suh, M. H. Kabir, U. Kang, J. W. Lee, J. Yu et al., Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers, Experimental and Molecular Medicine, vol.7, issue.Pt 5, pp.36-44, 2012.
DOI : 10.1006/jsre.1996.0219

G. Taraboletti, D. D. Roberts, and L. A. Liotta, Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains, The Journal of Cell Biology, vol.105, issue.5, pp.2409-2415, 1987.
DOI : 10.1083/jcb.105.5.2409

V. Vafaizadeh, U. Graab, T. Darvishi, R. Machado, and B. Groner, Transforming growth factor beta signaling regulates the invasiveness of normal mammary epithelial cells and the metastasis formation of tumor cells, Horm Mol Biol Clin Investig, vol.10, pp.227-239, 2012.

Z. Wang, M. Wang, F. Yang, W. Nie, F. Chen et al., Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis The effect of thrombospondin-1 on breast cancer metastasis, Eur J Clin Pharmacol Breast Cancer Res Treat, vol.70, issue.114, pp.531-538, 2009.

J. M. Zarzynska, Two Faces of TGF-Beta1 in Breast Cancer, Mediators of Inflammation, vol.2, issue.2, 2014.
DOI : 10.1038/nchembio.500

R. Akhurst and A. Hata, Targeting the TGF?? signalling pathway in disease, Nature Reviews Drug Discovery, vol.298, issue.10, pp.790-811, 2012.
DOI : 10.1152/ajpheart.01048.2009

G. Algire, H. Chalkley, W. Earle, F. Legallais, H. Park et al., Vascular reactions of normal and malignant tissues in vivo. III. Vascular reactions' of mice to fibroblasts treated in vitro with methylcholanthrene, J Natl Cancer Inst, vol.11, pp.555-580, 1950.

K. Alitalo, T. Tammela, and T. Petrova, Lymphangiogenesis in development and human disease, Nature, vol.36, issue.7070, pp.946-953, 2005.
DOI : 10.1038/ng1383

C. Alix-panabières, K. Bartkowiak, and K. Pantel, Functional studies on circulating and disseminated tumor cells in carcinoma patients, Molecular Oncology, vol.5, issue.3, pp.443-449, 2016.
DOI : 10.18632/oncotarget.2592

C. Alix-panabieres and K. Pantel, Challenges in circulating tumour cell research, Nature Reviews Cancer, vol.497, issue.9, pp.623-631, 2014.
DOI : 10.1038/nature12065

M. Attur, G. Palmer, H. Mussawir, M. Dave, C. Teixeira et al., TGF-?? activation, The FASEB Journal, vol.23, issue.1, pp.79-89, 2009.
DOI : 10.1096/fj.08-114363

N. Baenziger, G. Brodie, and P. Majerus, A Thrombin-Sensitive Protein of Human Platelet Membranes, Proceedings of the National Academy of Sciences, vol.68, issue.1, pp.240-243, 1971.
DOI : 10.1073/pnas.68.1.240

A. Bandyopadhyay, L. Wang, J. Agyin, Y. Tang, S. Lin et al., Doxorubicin in Combination with a Small TGF?? Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models, PLoS ONE, vol.5, issue.4, p.10365, 2010.
DOI : 10.1371/journal.pone.0010365.s004

T. Barker, M. Pallero, M. Macewen, S. Tilden, A. Woods et al., Thrombospondin-1-induced Focal Adhesion Disassembly in Fibroblasts Requires Thy-1 Surface Expression, Lipid Raft Integrity, and Src Activation, Journal of Biological Chemistry, vol.147, issue.22, pp.23510-23516, 2004.
DOI : 10.1074/jbc.M200427200

D. Bates, T. Cui, J. Doughty, M. Winkler, M. Sugiono et al., VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Is Down-Regulated in Renal Cell Carcinoma, Cancer Research, vol.62, pp.4123-4131, 2002.

S. Baylin, Resistance, epigenetics and the cancer ecosystem, Nature Medicine, vol.454, issue.3, pp.288-289, 2011.
DOI : 10.1038/nature07056

G. Bergers and L. Benjamin, Angiogenesis: Tumorigenesis and the angiogenic switch, Nature Reviews Cancer, vol.3, issue.6, pp.401-410, 2003.
DOI : 10.1038/nrc1093

G. Bergers and D. Hanahan, Modes of resistance to anti-angiogenic therapy, Nature Reviews Cancer, vol.25, issue.8, pp.592-603, 2008.
DOI : 10.1016/S0002-9440(10)64083-7

K. Bleuel, S. Popp, N. Fusenig, E. Stanbridge, and P. Boukamp, Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization, Proceedings of the National Academy of Sciences, vol.235, issue.2, pp.2065-2070, 1999.
DOI : 10.1006/excr.1997.3681

K. Bourd-boittin, D. Bonnier, A. Leyme, B. Mari, P. Tuffery et al., Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta, Hepatology, vol.34, issue.Pt 3, pp.2173-2184, 2011.
DOI : 10.1093/nar/gkl289

G. Byrne, K. Hayden, G. Mcdowell, H. Lang, C. Kirwan et al., Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer, Int J Oncol, vol.31, pp.1127-1132, 2007.

M. Calzada, J. Sipes, H. Krutzsch, P. Yurchenco, D. Annis et al., Integrin, Journal of Biological Chemistry, vol.148, issue.42, pp.40679-40687, 2003.
DOI : 10.1074/jbc.M209288200

M. Campone, I. Valo, P. Jézéquel, M. Moreau, A. Boissard et al., Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples, Molecular & Cellular Proteomics, vol.240, issue.4, pp.2936-2946, 2015.
DOI : 10.1158/1055-9965.EPI-09-0456

M. Carlevaro, S. Cermelli, R. Cancedda, D. Cancedda, and F. , Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation, Journal of cell science, vol.113, pp.59-69, 2000.

P. Carmeliet, Mechanisms of angiogenesis and arteriogenesis, Nature Medicine, vol.153, issue.4, pp.389-395, 2000.
DOI : 10.1016/S0002-9440(10)65654-4

P. Carmeliet, Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-936, 2005.
DOI : 10.1053/j.seminoncol.2004.03.034

P. Carmeliet and R. Jain, Molecular mechanisms and clinical applications of angiogenesis, Nature, vol.464, issue.7347, pp.298-307, 2011.
DOI : 10.1038/nature08889

R. Coffey, J. Sipes, N. Bascom, C. Graves-deal, R. Pennington et al., Growth modulation of mouse keratinocytes by transforming growth factors, Cancer Res, vol.48, pp.1596-1602, 1988.

G. Colditz, K. Kaphingst, S. Hankinson, and B. Rosner, Family history and risk of breast cancer: nurses??? health study, Breast Cancer Research and Treatment, vol.8, issue.2, pp.1097-1104, 2012.
DOI : 10.1001/jama.296.2.193

D. Dawson, S. Pearce, R. Zhong, R. Silverstein, W. Frazier et al., CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells, CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells, pp.707-717, 1997.
DOI : 10.1006/bbrc.1996.1813

F. De-fraipont, M. Keramidas, E. Atifi, M. Chambaz, E. Berger et al., Expression of the thrombospondin 1 fragment 167???569 in C6 glioma cells stimulates tumorigenicity despite reduced neovascularization, Oncogene, vol.23, issue.20, pp.3642-3649, 2004.
DOI : 10.1006/bbrc.1995.2780

F. De-fraipont, A. Nicholson, J. Feige, V. Meir, and E. , Thrombospondins and tumor angiogenesis, Trends in Molecular Medicine, vol.7, issue.9, pp.401-407, 2001.
DOI : 10.1016/S1471-4914(01)02102-5

R. Demicheli, Tumour dormancy: findings and hypotheses from clinical research on breast cancer, Seminars in Cancer Biology, vol.11, issue.4, pp.297-306, 2001.
DOI : 10.1006/scbi.2001.0385

P. Dicesare, N. Hauser, D. Lehman, S. Pasumarti, and M. Paulsson, Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon, FEBS Letters, vol.227, issue.2, pp.237-240, 1994.
DOI : 10.1038/227680a0

J. Ebos, C. Lee, W. Cruz-munoz, G. Bjarnason, J. Christensen et al., Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis, Cancer Cell, vol.15, issue.3, pp.232-239, 2009.
DOI : 10.1016/j.ccr.2009.01.021

G. Eelen, P. De-zeeuw, M. Simons, and P. Carmeliet, Endothelial Cell Metabolism in Normal and Diseased Vasculature, Circulation Research, vol.116, issue.7, pp.1231-1244, 2015.
DOI : 10.1161/CIRCRESAHA.116.302855

L. Ellis and D. Hicklin, VEGF-targeted therapy: mechanisms of anti-tumour activity, Nature Reviews Cancer, vol.119, issue.8, pp.579-591, 2008.
DOI : 10.4161/cbt.6.8.4363

L. Ellis and D. Reardon, The nuances of therapy, Nature, vol.25, issue.7236, pp.290-292, 2009.
DOI : 10.1038/458290a

C. Elston and I. Ellis, pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.9, issue.5, pp.154-161, 2002.
DOI : 10.1038/bjc.1987.230

N. Ferrara, VEGF-A: a critical regulator of blood vessel growth, European cytokine network, vol.20, pp.158-163, 2009.

N. Ferrara, H. Gerber, and J. Lecouter, The biology of VEGF and its receptors, Nature Medicine, vol.99, issue.21, pp.669-676, 2003.
DOI : 10.1073/pnas.152324099

C. Ferrer and M. Reginato, Cancer Metabolism: Cross Talk Between Signaling and O-GlcNAcylation, Methods Mol Biol, vol.1176, pp.73-88, 2014.
DOI : 10.1007/978-1-4939-0992-6_7

S. Filleur, O. Volpert, A. Degeorges, C. Voland, F. Reiher et al., In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects, Genes & Development, vol.15, issue.11, pp.1373-1382, 2001.
DOI : 10.1101/gad.193501

V. Firlej, J. Mathieu, C. Gilbert, L. Lemonnier, J. Nakhle et al., Thrombospondin-1 Triggers Cell Migration and Development of Advanced Prostate Tumors, Cancer Research, vol.71, issue.24, pp.7649-7658, 2011.
DOI : 10.1158/0008-5472.CAN-11-0833

K. Fischer, A. Durrans, S. Lee, J. Sheng, F. Li et al., Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance, Nature, vol.5, issue.7579, pp.472-476, 2015.
DOI : 10.1038/cddis.2014.115
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662610/pdf

J. Folkman, Tumor Angiogenesis: Therapeutic Implications, New England Journal of Medicine, vol.285, pp.1182-1186, 1971.

S. Fouquet, V. Lugo-martínez, A. Faussat, F. Renaud, P. Cardot et al., Early Loss of E-cadherin from Cell-Cell Contacts Is Involved in the Onset of Anoikis in Enterocytes, Journal of Biological Chemistry, vol.281, issue.41, pp.43061-43069, 2004.
DOI : 10.1038/nrc822

S. Frisch, M. Schaller, and B. Cieply, Mechanisms that link the oncogenic epithelial???mesenchymal transition to suppression of anoikis, Journal of Cell Science, vol.126, issue.1, pp.21-29, 2013.
DOI : 10.1242/jcs.120907

E. Gerstner, D. Duda, E. Di-tomaso, P. Ryg, J. Loeffler et al., VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer, Nature Reviews Clinical Oncology, vol.17, issue.4, pp.229-236, 2009.
DOI : 10.1016/j.ijrobp.2006.10.010

D. Gilkes, G. Semenza, and D. Wirtz, Hypoxia and the extracellular matrix: drivers of tumour metastasis, Nature Reviews Cancer, vol.18, issue.6, pp.430-439, 2014.
DOI : 10.1096/fj.03-0699com

Y. Glinka and J. Prud-'homme-gé, Neuropilin-1 is a receptor for transforming growth factor ??-1, activates its latent form, and promotes regulatory T cell activity, Journal of Leukocyte Biology, vol.17, issue.1, pp.302-310, 2008.
DOI : 10.1016/j.ceb.2005.01.001

D. Good, P. Polverini, F. Rastinejad, L. Beau, M. Lemons et al., A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin., Proceedings of the National Academy of Sciences, vol.87, issue.17, pp.6624-6628, 1990.
DOI : 10.1073/pnas.87.17.6624

D. Guerrero, R. Guarch, A. Ojer, J. Casas, S. Ropero et al., Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma, BJU International, vol.433, issue.6, pp.747-755, 2008.
DOI : 10.1016/S0002-9440(10)62506-0

W. Guo, Z. Dong, M. He, Y. Guo, J. Guo et al., Aberrant Methylation of Thrombospondin-1 and Its Association with Reduced Expression in Gastric Cardia Adenocarcinoma, Journal of Biomedicine and Biotechnology, vol.177, issue.6, 2010.
DOI : 10.4049/jimmunol.177.6.3534

B. Gyorffy, P. Surowiak, J. Budczies, and A. Lanczky, Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer, PLoS ONE, vol.56, issue.12, p.82241, 2013.
DOI : 10.1371/journal.pone.0082241.s002

D. Hanahan and R. Weinberg, The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000.
DOI : 10.1016/S0092-8674(00)81683-9

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

R. Haq and P. Gulasingam, Duration of trastuzumab in patients with HER2-positive metastatic breast cancer in prolonged remission, Current Oncology, vol.23, issue.2, pp.91-95, 2016.
DOI : 10.3747/co.23.2743

N. Harbeck, C. Thomssen, and M. Gnant, St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion, Breast Care, vol.8, issue.2, pp.102-109, 2013.
DOI : 10.1159/000351193

S. Hatfield, J. Kjaergaard, D. Lukashev, T. Schreiber, B. Belikoff et al., Immunological mechanisms of the antitumor effects of supplemental oxygenation, Science Translational Medicine, vol.60, issue.277, pp.277-230, 2015.
DOI : 10.1016/j.jcrc.2006.12.002

E. Hay, An Overview of Epithelio-Mesenchymal Transformation, Cells Tissues Organs, vol.154, issue.1, pp.8-20, 1995.
DOI : 10.1159/000147748

J. Henkin and O. Volpert, Therapies using anti-angiogenic peptide mimetics of thrombospondin-1, Expert Opinion on Therapeutic Targets, vol.10, issue.2, pp.1369-1386, 2011.
DOI : 10.1158/1535-7163.MCT-11-0402

E. Hirata, G. Maria, R. Viros, A. Hooper, S. Spencer-dene et al., Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin ??1/FAK Signaling, Cancer Cell, vol.27, issue.4, pp.574-588, 2015.
DOI : 10.1016/j.ccell.2015.03.008
URL : https://doi.org/10.1016/j.ccell.2015.03.008

P. Hoffman, A. Mauer, and E. Vokes, Lung cancer, The Lancet, vol.355, issue.9202, pp.479-485, 2000.
DOI : 10.1016/S0140-6736(00)82038-3

J. Hofsteenge, K. Huwiler, B. Macek, D. Hess, J. Lawler et al., -Fucosylation of the Thrombospondin Type 1 Module, Journal of Biological Chemistry, vol.267, issue.9, pp.6485-6498, 2001.
DOI : 10.1021/bi00223a004

H. Horiguchi, S. Yamagata, R. Qian, Z. Kagawa, S. Sakashita et al., Thrombospondin-1 is highly expressed in desmoplastic components of invasive ductal carcinoma of the breast and associated with lymph node metastasis. The journal of medical investigation, JMI, vol.60, pp.91-96, 2013.

P. Hughes, S. Caenepeel, and L. Wu, Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer, Trends in Immunology, vol.37, issue.7
DOI : 10.1016/j.it.2016.04.010

H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth et al., Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.350, issue.23, pp.2335-2342, 2004.
DOI : 10.1056/NEJMoa032691

T. Ichii, H. Koyama, S. Tanaka, A. Shioi, Y. Okuno et al., Thrombospondin-1 Mediates Smooth Muscle Cell Proliferation Induced by Interaction With Human Platelets, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.8, pp.1286-1292, 2002.
DOI : 10.1161/01.ATV.0000024684.67566.45

J. Im, W. Fu, H. Wang, S. Bhatia, D. Hammer et al., Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation, Cancer Research, vol.64, issue.23, pp.8613-8619, 2004.
DOI : 10.1158/0008-5472.CAN-04-2078

T. Imai, A. Horiuchi, C. Wang, K. Oka, S. Ohira et al., Hypoxia Attenuates the Expression of E-Cadherin via Up-Regulation of SNAIL in Ovarian Carcinoma Cells, The American Journal of Pathology, vol.163, issue.4, pp.1437-1447, 2003.
DOI : 10.1016/S0002-9440(10)63501-8

M. Inukai, A. Hara, M. Yasui, T. Kumabe, T. Matsumoto et al., Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1??/Akt axis in glioblastoma, Human Pathology, vol.46, issue.10
DOI : 10.1016/j.humpath.2015.06.008

M. Iruela-arispe, M. Lombardo, H. Krutzsch, J. Lawler, and D. Roberts, Inhibition of Angiogenesis by Thrombospondin-1 Is Mediated by 2 Independent Regions Within the Type 1 Repeats, Circulation, vol.100, issue.13, pp.1423-1431, 1999.
DOI : 10.1161/01.CIR.100.13.1423

J. Isenberg, G. Martin-manso, J. Maxhimer, and D. Roberts, Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies, Nature Reviews Cancer, vol.14, issue.3, pp.182-194, 2009.
DOI : 10.1016/S0002-9440(10)63042-8

J. Isenberg, M. Romeo, M. Abu-asab, M. Tsokos, A. Oldenborg et al., Increasing Survival of Ischemic Tissue by Targeting CD47, Circulation Research, vol.100, issue.5, pp.712-720, 2007.
DOI : 10.1161/01.RES.0000259579.35787.4e

R. Jain, Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy, Science, vol.307, issue.5706, pp.58-62, 2005.
DOI : 10.1126/science.1104819

S. Jain, M. Zuka, J. Liu, S. Russell, J. Dent et al., Platelet glycoprotein Ib?? supports experimental lung metastasis, Proceedings of the National Academy of Sciences, vol.267, issue.18, pp.9024-9028, 2007.
DOI : 10.1182/blood-2006-01-011817
URL : http://www.pnas.org/content/104/21/9024.full.pdf

A. Jayachandran, M. Anaka, P. Prithviraj, C. Hudson, S. Mckeown et al., Thrombospondin 1 promotes an aggressive phenotype through epithelial-tomesenchymal transition in human melanoma, Oncotarget, vol.5, pp.5782-5797, 2014.

G. Jayson, R. Kerbel, L. Ellis, and A. Harris, Antiangiogenic therapy in oncology: current status and future directions, The Lancet, vol.388, issue.10043, 2016.
DOI : 10.1016/S0140-6736(15)01088-0

G. Jeong, Thrombospondin-1 and Inhibition of Tumor Growth, Korean Journal of Physical Anthropology, vol.28, issue.4, pp.175-184, 2015.
DOI : 10.11637/kjpa.2015.28.4.175

Y. Kang, P. Siegel, W. Shu, M. Drobnjak, S. Kakonen et al., A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, vol.3, issue.6, pp.537-549, 2003.
DOI : 10.1016/S1535-6108(03)00132-6
URL : https://doi.org/10.1016/s1535-6108(03)00132-6

T. Karrison, D. Ferguson, and P. Meier, Dormancy of Mammary Carcinoma After Mastectomy, JNCI Journal of the National Cancer Institute, vol.63, issue.1, pp.80-85, 1999.
DOI : 10.1002/1097-0142(19890101)63:1<188::AID-CNCR2820630130>3.0.CO;2-M

T. Kawataki, H. Naganuma, A. Sasaki, H. Yoshikawa, K. Tasaka et al., Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma, Neuropathology, vol.3, issue.3, pp.161-169, 2000.
DOI : 10.1038/359845a0

S. Kazerounian, K. Yee, and J. Lawler, Thrombospondins: from structure to therapeutics, Cellular and Molecular Life Sciences, vol.65, issue.5, pp.700-712, 2008.
DOI : 10.1007/s00018-007-7486-z
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752021/pdf

R. Kerbel, Y. J. Tran, J. Man, S. Viloria-petit, A. Klement et al., Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches, Cancer and Metastasis Reviews, vol.20, issue.1/2, pp.79-86, 2001.
DOI : 10.1023/A:1013172910858

Y. Kienast, L. Von-baumgarten, M. Fuhrmann, W. Klinkert, R. Goldbrunner et al., Real-time imaging reveals the single steps of brain metastasis formation, Nature Medicine, vol.44, issue.1, pp.116-122, 2010.
DOI : 10.4161/cc.5.16.2864

K. Kim, B. Li, J. Winer, M. Armanini, N. Gillett et al., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature, vol.362, issue.6423, pp.841-844, 1993.
DOI : 10.1038/362841a0

A. Koong, V. Mehta, Q. Le, G. Fisher, D. Terris et al., Pancreatic tumors show high levels of hypoxia, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.4, pp.919-922, 2000.
DOI : 10.1016/S0360-3016(00)00803-8

M. Kuijpers, S. De-witt, R. Nergiz-unal, R. Van-kruchten, S. Korporaal et al., Supporting Roles of Platelet Thrombospondin-1 and CD36 in Thrombus Formation on Collagen, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.34, issue.6, pp.1187-1192, 2014.
DOI : 10.1161/ATVBAHA.113.302917

M. Labelle, S. Begum, H. Richard, and O. , Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis, Cancer Cell, vol.20, issue.5, pp.576-590, 2011.
DOI : 10.1016/j.ccr.2011.09.009
URL : https://doi.org/10.1016/j.ccr.2011.09.009

S. Lamouille, J. Xu, and R. Derynck, Molecular mechanisms of epithelial???mesenchymal transition, Nature Reviews Molecular Cell Biology, vol.22, issue.3, pp.178-196, 2014.
DOI : 10.1016/j.ccr.2012.10.012

J. Lathia, J. Gallagher, J. Myers, M. Li, A. Vasanji et al., Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells, PLoS ONE, vol.324, issue.12, p.24807, 2011.
DOI : 10.1371/journal.pone.0024807.g005

J. Lawler, M. Duquette, C. Whittaker, J. Adams, K. Mchenry et al., Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family, The Journal of Cell Biology, vol.120, issue.4, pp.1059-1067, 1993.
DOI : 10.1083/jcb.120.4.1059

J. Lawler, M. Sunday, V. Thibert, M. Duquette, E. George et al., Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia., Journal of Clinical Investigation, vol.101, issue.5, pp.982-992, 1998.
DOI : 10.1172/JCI1684

J. Lawler, R. Weinstein, and R. Hynes, Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors, The Journal of Cell Biology, vol.107, issue.6, pp.2351-2361, 1988.
DOI : 10.1083/jcb.107.6.2351

C. Lee, M. Heijn, E. Di-tomaso, G. Griffon-etienne, M. Ancukiewicz et al., Anti-Vascular Endothelial Growth Factor Treatment Augments Tumor Radiation Response under Normoxic or Hypoxic Conditions, Cancer Research, vol.60, pp.5565-5570, 2000.

J. Lee, D. Bhang, A. Beede, T. Huang, B. Stripp et al., Lung Stem Cell Differentiation in Mice Directed by Endothelial Cells via a BMP4-NFATc1-Thrombospondin-1 Axis, Cell, vol.156, issue.3, pp.440-455, 2014.
DOI : 10.1016/j.cell.2013.12.039

K. Levental, H. Yu, K. L. Lakins, J. Egeblad, M. Erler et al., Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling, Cell, vol.139, issue.5, pp.891-906, 2009.
DOI : 10.1016/j.cell.2009.10.027
URL : https://doi.org/10.1016/j.cell.2009.10.027

Q. Li, N. Ahuja, P. Burger, and J. Issa, Methylation and silencing of the Thrombospondin-1 promoter in human cancer, Oncogene, vol.18, issue.21, pp.3284-3289, 1999.
DOI : 10.1002/ijc.2910590209

Z. Liao, R. Komaki, L. Milas, C. Yuan, M. Kies et al., A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable, Unresectable Non?Small Cell Lung Cancer. Clinical Cancer Research, vol.11, pp.3342-3348, 2005.

M. Liberti and J. Locasale, The Warburg Effect: How Does it Benefit Cancer Cells?, Trends in Biochemical Sciences, vol.41, issue.3, pp.211-218, 2016.
DOI : 10.1016/j.tibs.2015.12.001

G. Lin, J. Wang, S. Li, J. Wang, L. Xu et al., Relationship and clinical significance of TGF-beta1 expression with Treg cell infiltration in hepatocellular carcinoma, Chinese Journal of Cancer, vol.29, issue.4, pp.403-407, 2010.
DOI : 10.5732/cjc.009.10628

A. Liu, P. Garg, S. Yang, P. Gong, M. Pallero et al., Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activation, 2009.

V. Liu, L. Wong, T. Jang, A. Shah, I. Park et al., Tumor Evasion of the Immune System by Converting CD4+CD25- T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-??, The Journal of Immunology, vol.178, issue.5, pp.2883-2892, 2007.
DOI : 10.4049/jimmunol.178.5.2883

Y. Liu, Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention, Journal of the American Society of Nephrology, vol.15, issue.1, pp.1-12, 2004.
DOI : 10.1097/01.ASN.0000106015.29070.E7

F. Marcucci, G. Stassi, D. Maria, and R. , Epithelial???mesenchymal transition: a new target in anticancer drug discovery, Nature Reviews Drug Discovery, vol.527, issue.5, 2016.
DOI : 10.1038/nature16064

B. Margosio, D. Marchetti, V. Vergani, R. Giavazzi, M. Rusnati et al., Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2, Blood, vol.102, issue.13, pp.4399-4406, 2003.
DOI : 10.1182/blood-2003-03-0893
URL : http://www.bloodjournal.org/content/bloodjournal/102/13/4399.full.pdf

J. Maxhimer, H. Shih, J. Isenberg, T. Miller, and D. Roberts, Thrombospondin-1/CD47 Blockade following Ischemia-Reperfusion Injury Is Tissue Protective, Plastic and Reconstructive Surgery, vol.124, issue.6, pp.1880-1889, 2009.
DOI : 10.1097/PRS.0b013e3181bceec3
URL : http://europepmc.org/articles/pmc2794041?pdf=render

D. Mcdonald and P. Choyke, Imaging of angiogenesis: from microscope to clinic, Nature Medicine, vol.99, issue.suppl. 2, pp.713-725, 2003.
DOI : 10.1073/pnas.172398299

P. Mcdonald, S. Chafe, and S. Dedhar, Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction, Frontiers in Cell and Developmental Biology, vol.6, issue.400, p.27, 2016.
DOI : 10.1038/nri1806

Y. Mirochnik, A. Kwiatek, and O. Volpert, Thrombospondin and Apoptosis: Molecular Mechanisms and Use for Design of Complementation Treatments, Current Drug Targets, vol.9, issue.10, pp.851-862, 2008.
DOI : 10.2174/138945008785909347

A. Mitra, L. Mishra, and S. Li, EMT, CTCs and CSCs in tumor relapse and drug-resistance, Oncotarget, vol.6, issue.13, pp.10697-10711, 2015.
DOI : 10.18632/oncotarget.4037

J. Murphy-ullrich, S. Gurusiddappa, W. Frazier, and M. Höök, Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity, Journal of Biological Chemistry, vol.268, pp.26784-26789, 1993.

J. Murphy-ullrich and M. Poczatek, Activation of latent TGF-?? by thrombospondin-1: mechanisms and physiology, Cytokine & Growth Factor Reviews, vol.11, issue.1-2, pp.59-69, 2000.
DOI : 10.1016/S1359-6101(99)00029-5

V. Muthukkaruppan and R. Auerbach, Angiogenesis in the mouse cornea, Science, vol.205, issue.4413, pp.1416-1418, 1979.
DOI : 10.1126/science.472760

D. Ndishabandi, C. Duquette, G. Billah, M. Reyes, M. Duquette et al., Thrombospondin-1 Modulates Actin Filament Remodeling and Cell Motility in Mouse Mammary Tumor cells in Vitro, Discoveries (Craiova) 2, 2014.
DOI : 10.15190/d.2014.23

D. Nguyen, P. Bos, and J. Massague, Metastasis: from dissemination to organ-specific colonization, Nature Reviews Cancer, vol.100, issue.4, pp.274-284, 2009.
DOI : 10.1016/S0002-9440(10)65628-3

B. Nieswandt, M. Hafner, B. Echtenacher, and D. Männel, Lysis of Tumor Cells by Natural Killer Cells in Mice Is Impeded by Platelets, Cancer Research, vol.59, pp.1295-1300, 1999.

C. Nucera, A. Porrello, Z. Antonello, M. Mekel, M. Nehs et al., B-RafV600E and thrombospondin-1 promote thyroid cancer progression, Proceedings of the National Academy of Sciences, vol.3, issue.2, pp.10649-10654, 2010.
DOI : 10.3181/00379727-212-44008
URL : http://www.pnas.org/content/107/23/10649.full.pdf

M. Okamoto, M. Ono, T. Uchiumi, H. Ueno, K. Kohno et al., Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor ?? in human cancer cells ??? transcriptional activation and messenger RNA stabilization, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1574, issue.1, pp.24-34, 2002.
DOI : 10.1016/S0167-4781(01)00345-1

D. Ortiz-masià, I. Díez, S. Calatayud, C. Hernández, J. Cosín-roger et al., Induction of CD36 and Thrombospondin-1 in Macrophages by Hypoxia-Inducible Factor 1 and Its Relevance in the Inflammatory Process, PLoS ONE, vol.23, issue.10, p.48535, 2012.
DOI : 10.1371/journal.pone.0048535.s001

M. Osada-oka, T. Ikeda, S. Akiba, and T. Sato, Hypoxia stimulates the autocrine regulation of migration of vascular smooth muscle cells via HIF-1??-dependent expression of thrombospondin-1, Journal of Cellular Biochemistry, vol.17, issue.5, pp.1918-1926, 2008.
DOI : 10.1161/01.ATV.17.10.2107

M. Paez-ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama et al., Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis, Cancer Cell, vol.15, issue.3, pp.220-231, 2009.
DOI : 10.1016/j.ccr.2009.01.027

T. Rege, J. Stewart, B. Dranka, E. Benveniste, R. Silverstein et al., Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1, Journal of Cellular Physiology, vol.278, issue.1, pp.94-103, 2009.
DOI : 10.1016/S0002-9440(10)64986-3

M. Relf, S. Lejeune, P. Scott, S. Fox, K. Smith et al., Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis, Cancer Res, vol.57, pp.963-969, 1997.

S. Ribeiro, M. Poczatek, S. Schultz-cherry, M. Villain, and J. Murphy-ullrich, The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-??, Journal of Biological Chemistry, vol.264, issue.19, pp.13586-13593, 1999.
DOI : 10.1016/S0092-8674(00)80545-0

D. Roberts, Regulation of tumor growth and metastasis by thrombospondin-1., The FASEB Journal, vol.10, issue.10, pp.1183-1191, 1996.
DOI : 10.1096/fasebj.10.10.8751720

Y. Roh, Y. Kim, H. Choi, K. Lee, and M. Roh, Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer, Journal of Hepato-Biliary-Pancreatic Surgery, vol.9, issue.3, pp.315-321, 2009.
DOI : 10.1091/mbc.9.5.993

O. Schmidt-kittler, T. Ragg, A. Daskalakis, M. Granzow, A. Ahr et al., From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression, Proceedings of the National Academy of Sciences, vol.100, issue.3, pp.7737-7742, 2003.
DOI : 10.1073/pnas.0334858100

C. Seliger, P. Leukel, S. Moeckel, B. Jachnik, C. Lottaz et al., Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro, PLoS ONE, vol.17, issue.11, p.78935, 2013.
DOI : 10.1371/journal.pone.0078935.s003

E. Senkus, S. Kyriakides, S. Ohno, F. Penault-llorca, P. Poortmans et al., Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.34, issue.(Suppl 1), pp.8-30, 2015.
DOI : 10.1086/321805

Y. Shaked, F. Bertolini, S. Man, M. Rogers, D. Cervi et al., Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis, Cancer Cell, vol.7, issue.1, pp.101-111, 2005.
DOI : 10.1016/j.ccr.2004.11.023

S. Shapiro, T. Pines, A. Sturdee, D. Archer, D. Baber et al., RE: Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study, JNCI Journal of the National Cancer Institute, vol.107, issue.1, p.372, 2014.
DOI : 10.1007/s10549-007-9523-x

S. Sheen-chen, H. Chen, C. Sheen, H. Eng, and W. Chen, Serum Levels of Transforming Growth Factor ??1 in Patients With Breast Cancer, Archives of Surgery, vol.136, issue.8, pp.937-940, 1960.
DOI : 10.1001/archsurg.136.8.937

C. Sheridan, H. Kishimoto, R. Fuchs, S. Mehrotra, P. Bhat-nakshatri et al., CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis, Breast Cancer Research, vol.50, issue.5, p.59, 2006.
DOI : 10.1007/BF00204786

B. Sid, H. Sartelet, G. Bellon, E. Btaouri, H. Rath et al., Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth, Critical Reviews in Oncology/Hematology, vol.49, issue.3, pp.245-258, 2004.
DOI : 10.1016/j.critrevonc.2003.09.009

R. Silverstein and M. Febbraio, CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior, Science Signaling, vol.2, issue.72, pp.3-3, 2009.
DOI : 10.1126/scisignal.272re3

C. Simpson, K. Anyiwe, and A. Schimmer, Anoikis resistance and tumor metastasis, Cancer Letters, vol.272, issue.2, pp.177-185, 2008.
DOI : 10.1016/j.canlet.2008.05.029

H. Sinn and H. Kreipe, A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition, Breast Care, vol.8, issue.2, pp.149-154, 2013.
DOI : 10.1159/000350774

S. Smith, Regulation of angiogenesis in the endometrium, Trends in Endocrinology & Metabolism, vol.12, issue.4, pp.147-151, 2001.
DOI : 10.1016/S1043-2760(01)00379-4

J. Sockolosky, M. Dougan, J. Ingram, C. Ho, M. Kauke et al., Durable antitumor responses to CD47 blockade require adaptive immune stimulation, Proceedings of the National Academy of Sciences, vol.158, issue.2, pp.2646-2654, 2016.
DOI : 10.1016/j.jim.2007.04.008
URL : http://www.pnas.org/content/113/19/E2646.full.pdf

E. Soehngen, A. Schaefer, J. Koeritzer, V. Huelsmeyer, C. Zimmer et al., Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells, Brain Tumor Pathology, vol.137, issue.4, pp.247-256, 2014.
DOI : 10.1007/s00432-010-0955-z

T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.179, issue.1, pp.10869-10874, 2001.
DOI : 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O

N. Srivastava and D. Mcdermott, Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape, Cancer management and research, vol.6, pp.279-289, 2014.

O. Stenina-adognravi, Invoking the power of thrombospondins: Regulation of thrombospondins expression, Matrix Biology, vol.37, pp.69-82, 2014.
DOI : 10.1016/j.matbio.2014.02.001

M. Streit, P. Velasco, L. Brown, M. Skobe, L. Richard et al., Overexpression of Thrombospondin-1 Decreases Angiogenesis and Inhibits the Growth of Human Cutaneous Squamous Cell Carcinomas, The American Journal of Pathology, vol.155, issue.2, pp.441-452, 1999.
DOI : 10.1016/S0002-9440(10)65140-1

E. Suh, M. Kabir, U. Kang, J. Lee, J. Yu et al., Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers, Experimental and Molecular Medicine, vol.7, issue.Pt 5, pp.36-44, 2012.
DOI : 10.1006/jsre.1996.0219

E. Swan, S. Jasser, F. Holsinger, D. Doan, C. Bucana et al., Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer, Oral Oncology, vol.39, issue.7, pp.648-655, 2003.
DOI : 10.1016/S1368-8375(03)00049-6

M. Sweetwyne and J. Murphy-ullrich, Thrombospondin1 in tissue repair and fibrosis: TGF-??-dependent and independent mechanisms, Matrix Biology, vol.31, issue.3, pp.178-186, 2012.
DOI : 10.1016/j.matbio.2012.01.006

V. Szabo, E. Bugyik, K. Dezso, N. Ecker, P. Nagy et al., Mechanism of tumour vascularization in experimental lung metastases, The Journal of Pathology, vol.396, issue.3, pp.384-396, 2015.
DOI : 10.1007/BF00428501

Á. Szö?r, L. Ujlaky-nagy, G. Tóth, J. Szöll?si, and G. Vereb, Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms, Cellular Signalling, vol.28, issue.2, pp.81-93, 2016.
DOI : 10.1016/j.cellsig.2015.11.012

M. Takeichi, Dynamic contacts: rearranging adherens junctions to drive epithelial remodelling, Nature Reviews Molecular Cell Biology, vol.5, issue.6, pp.397-410, 2014.
DOI : 10.1016/S1097-2765(00)80447-5

W. Tam and R. Weinberg, The epigenetics of epithelial-mesenchymal plasticity in cancer, Nature Medicine, vol.63, issue.11, pp.1438-1449, 2013.
DOI : 10.1016/j.cell.2007.05.022

M. Tenan, G. Fulci, M. Albertoni, A. Diserens, M. Hamou et al., Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells, The Journal of Experimental Medicine, vol.260, issue.10, pp.1789-1798, 2000.
DOI : 10.1083/jcb.116.1.209

L. Terraneo, E. Virgili, A. Caretti, P. Bianciardi, and M. Samaja, In vivo hyperoxia induces hypoxia-inducible factor-1?? overexpression in LNCaP tumors without affecting the tumor growth rate, The International Journal of Biochemistry & Cell Biology, vol.51, pp.65-74, 2014.
DOI : 10.1016/j.biocel.2014.03.019

J. Thiery, Epithelial???mesenchymal transitions in development and pathologies, Current Opinion in Cell Biology, vol.15, issue.6, pp.740-746, 2003.
DOI : 10.1016/j.ceb.2003.10.006

Y. Tien, K. Chang, Y. Jeng, P. Lee, M. Wu et al., Tumor Angiogenesis and Its Possible Role in Intravasation of Colorectal Epithelial Cells, Clinical Cancer Research, vol.7, pp.1627-1632, 2001.

J. Tse, G. Cheng, J. Tyrrell, S. Wilcox-adelman, Y. Boucher et al., Mechanical compression drives cancer cells toward invasive phenotype, Proceedings of the National Academy of Sciences, vol.20, issue.1, pp.911-916, 2012.
DOI : 10.1039/B613349E
URL : http://www.pnas.org/content/109/3/911.full.pdf

R. Tucker, C. Hagios, R. Chiquet-ehrismann, J. Lawler, R. Hall et al., Thrombospondin-1 and neural crest cell migration. Developmental dynamics : an official publication of the, pp.312-322, 1999.
DOI : 10.1002/(sici)1097-0177(199904)214:4<312::aid-aja4>3.0.co;2-a
URL : http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-0177(199904)214:4<312::AID-AJA4>3.0.CO;2-A/pdf

J. Tung, J. Barnes, S. Desai, C. Sistrunk, M. Conklin et al., Tumor mechanics and metabolic dysfunction, Free Radical Biology and Medicine, vol.79, pp.269-280, 2015.
DOI : 10.1016/j.freeradbiomed.2014.11.020
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339308/pdf

G. Tuszynski, T. Gasic, V. Rothman, K. Knudsen, and G. Gasic, Thrombospondin, a potentiator of tumor cell metastasis, Cancer Res, vol.47, pp.4130-4133, 1987.

S. Vallabhajosula, L. Solnes, and B. Vallabhajosula, A Broad Overview of Positron Emission Tomography Radiopharmaceuticals and Clinical Applications: What Is New?, Seminars in Nuclear Medicine, vol.41, issue.4, pp.246-264, 2011.
DOI : 10.1053/j.semnuclmed.2011.02.003

A. Van-der-veldt, M. Lubberink, I. Bahce, M. Walraven, M. De-boer et al., Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs, Cancer Cell, vol.21, issue.1, pp.82-91, 2012.
DOI : 10.1016/j.ccr.2011.11.023

M. Vander-heiden, L. Cantley, and C. Thompson, Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation, Science, vol.26, issue.1, pp.1029-1033, 2009.
DOI : 10.1038/nrc2536

D. Veliceasa, M. Ivanovic, F. Hoepfner, P. Thumbikat, O. Volpert et al., Transient potential receptor channel???4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma, FEBS Journal, vol.37, issue.Suppl. 3, pp.6365-6377, 2007.
DOI : 10.1073/pnas.87.17.6624

T. Vincent, E. Neve, J. Johnson, A. Kukalev, F. Rojo et al., A SNAIL1???SMAD3/4 transcriptional repressor complex promotes TGF-?? mediated epithelial???mesenchymal transition, Nature Cell Biology, vol.91, issue.8, pp.943-950, 2009.
DOI : 10.1002/(SICI)1097-0215(19990531)81:5<748::AID-IJC14>3.3.CO;2-Y

O. Volpert, J. Lawler, and N. Bouck, A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1, Proceedings of the National Academy of Sciences, vol.73, issue.11, pp.6343-6348, 1998.
DOI : 10.1002/1097-0142(19940601)73:11<2853::AID-CNCR2820731131>3.0.CO;2-9

O. Volpert, T. Zaichuk, W. Zhou, F. Reiher, T. Ferguson et al., Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium???derived factor, Nature Medicine, vol.67, issue.4, pp.349-357, 2002.
DOI : 10.1161/01.ATV.20.2.309

H. Vos, S. Devarayalu, Y. De-vries, and P. Bornstein, Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family, J Biol Chem, vol.267, pp.12192-12196, 1992.

T. Wang, X. Qian, M. Granick, M. Solomon, V. Rothman et al., Thrombospondin-1 (TSP-1) Promotes the Invasive Properties of Human Breast Cancer, Journal of Surgical Research, vol.63, issue.1, pp.39-43, 1996.
DOI : 10.1006/jsre.1996.0219

X. Wang and W. Frazier, The Thrombospondin Receptor CD47 (IAP) Modulates and Associates with alpha 2beta 1 Integrin in Vascular Smooth Muscle Cells, Molecular Biology of the Cell, vol.9, issue.4, pp.865-874, 1998.
DOI : 10.1091/mbc.9.4.865

R. Warren, H. Yuan, M. Matli, N. Gillett, and N. Ferrara, Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis., Journal of Clinical Investigation, vol.95, issue.4, 1995.
DOI : 10.1172/JCI117857

D. Weinstat-saslow, V. Zabrenetzky, K. Vanhoutte, W. Frazier, D. Roberts et al., Transfection of Thrombospondin 1 Complementary DNA into a Human Breast Carcinoma Cell Line Reduces Primary Tumor Growth, Metastatic Potential, and Angiogenesis, Cancer Research, vol.54, pp.6504-6511, 1994.

M. Wendt, J. Smith, and W. Schiemann, Transforming growth factor-??-induced epithelial???mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression, Oncogene, vol.24, issue.49, pp.6485-6498, 2010.
DOI : 10.1038/onc.2010.377
URL : http://www.nature.com/onc/journal/v29/n49/pdf/onc2010377a.pdf

T. Wight, G. Raugi, S. Mumby, and P. Bornstein, Light microscopic immunolocation of thrombospondin in human tissues. The journal of histochemistry and cytochemistry : official journal of the, Histochemistry Society, vol.33, pp.295-302, 1985.

J. Wilting, C. B. Yuan, L. Eichmann, and A. , Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis, Naturwissenschaften, vol.90, issue.10, pp.433-448, 2003.
DOI : 10.1007/s00114-003-0455-y

S. Wong and R. Hynes, Lymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide?, Cell Cycle, vol.5, issue.8, pp.812-817, 2006.
DOI : 10.4161/cc.5.8.2646
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459485/pdf

J. Wu and C. Staton, Anti-angiogenic drug discovery: lessons from the past and thoughts for the future, Expert Opinion on Drug Discovery, vol.28, issue.11, pp.723-743, 2012.
DOI : 10.1093/qjmed/hcr139

J. Xu, S. Acharya, O. Sahin, Q. Zhang, Y. Saito et al., 14-3-3?? Turns TGF-?????s Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2, Cancer Cell, vol.27, issue.2, pp.177-192, 2015.
DOI : 10.1016/j.ccell.2014.11.025

M. Yang, M. Wu, S. Chiou, P. Chen, S. Chang et al., Direct regulation of TWIST by HIF-1?? promotes metastasis, Nature Cell Biology, vol.127, issue.3, pp.295-305, 2008.
DOI : 10.1101/gad.13.17.2207

Q. Yang, S. Liu, Y. Tian, H. Salwen, A. Chlenski et al., Methylation-associated Silencing of the Thrombospondin-1 Gene in Human Neuroblastoma, Cancer Research, vol.63, pp.6299-6310, 2003.

K. Yee, C. Connolly, M. Duquette, S. Kazerounian, R. Washington et al., The effect of thrombospondin-1 on breast cancer metastasis, Breast Cancer Research and Treatment, vol.31, issue.Pt 4, pp.85-96, 2009.
DOI : 10.1091/mbc.3.2.181

M. Yu, A. Bardia, B. Wittner, S. Stott, M. Smas et al., Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition, Science, vol.2, issue.5, pp.580-584, 2013.
DOI : 10.1002/emmm.201000070
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760262/pdf

J. Zarzynska, Two Faces of TGF-Beta1 in Breast Cancer, Mediators of Inflammation, vol.2, issue.2, p.141747, 2014.
DOI : 10.1038/nchembio.500

B. Zetter, The scientific contributions of M. Judah Folkman to cancer research, Nature Reviews Cancer, vol.10, issue.8, pp.647-654, 2008.
DOI : 10.1056/NEJM199101033240101

X. Zhang, S. Kazerounian, M. Duquette, C. Perruzzi, J. Nagy et al., Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level, The FASEB Journal, vol.23, issue.10, pp.3368-3376, 2009.
DOI : 10.1096/fj.09-131649

M. Zhou, Y. Zhao, Y. Ding, H. Liu, Z. Liu et al., Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol, Molecular Cancer, vol.9, issue.1, p.33, 2010.
DOI : 10.1186/1476-4598-9-33

D. Zhu, C. Cheng, and B. Pauli, Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule., Proceedings of the National Academy of Sciences, vol.88, issue.21, pp.9568-9572, 1991.
DOI : 10.1073/pnas.88.21.9568

A. Zomer, C. Maynard, V. Frederik, J. Kamermans, A. Schäfer et al., In??Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior, Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior, pp.1046-1057, 2015.
DOI : 10.1016/j.cell.2015.04.042

W. Zou, Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nature Reviews Cancer, vol.96, issue.4, pp.263-274, 2005.
DOI : 10.1073/pnas.96.26.15074